CALCRL encodes calcitonin receptor–like, a neuropeptide receptor involved in blood pressure regulation, cell proliferation, and apoptosis.45 In Mendelian randomization analysis, arterial CALCRL expression was associated with an increased risk of breast cancer but a reduced risk of CAD. This evidence concerns the gene CALCRL and breast carcinoma.